Claudia Wellbrock

7.8k total citations · 2 hit papers
57 papers, 5.6k citations indexed

About

Claudia Wellbrock is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Claudia Wellbrock has authored 57 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 29 papers in Cell Biology and 19 papers in Oncology. Recurrent topics in Claudia Wellbrock's work include Melanoma and MAPK Pathways (27 papers), melanin and skin pigmentation (14 papers) and Cell Adhesion Molecules Research (11 papers). Claudia Wellbrock is often cited by papers focused on Melanoma and MAPK Pathways (27 papers), melanin and skin pigmentation (14 papers) and Cell Adhesion Molecules Research (11 papers). Claudia Wellbrock collaborates with scholars based in United Kingdom, Germany and Spain. Claudia Wellbrock's co-authors include Richard Marais, Imanol Arozarena, Vanessa C. Gray‐Schopfer, Maria Karasarides, Manfred Schartl, Adam Hurlstone, Michael P. Smith, Jennifer Ferguson, Eva Geissinger and Petra Fischer and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Claudia Wellbrock

57 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melanoma biology and new targeted therapy

2007 1.1k citations Claudia Wellbrock, Richard Marais et al. profile →
The RAF proteins take centre stage

2004 920 citations Claudia Wellbrock, Richard Marais et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Wellbrock United Kingdom	32	4.0k	2.2k	1.2k	1.1k	627	57	5.6k
Francis Burrows United States	39	4.9k 1.2×	1.1k 0.5×	828 0.7×	1.1k 0.9×	496 0.8×	109	6.5k
Jinyan Du United States	26	4.2k 1.0×	2.1k 1.0×	1.6k 1.4×	1.0k 0.9×	1.0k 1.7×	37	6.3k
Nikolas K. Haass Australia	36	2.8k 0.7×	1.7k 0.8×	822 0.7×	572 0.5×	579 0.9×	99	4.3k
Keiran S.M. Smalley United States	53	5.9k 1.5×	4.0k 1.8×	1.3k 1.2×	1.2k 1.0×	837 1.3×	173	8.5k
Peter Blume‐Jensen United States	18	3.3k 0.8×	1.3k 0.6×	568 0.5×	840 0.7×	454 0.7×	25	5.0k
Hubing Shi China	33	5.5k 1.4×	3.4k 1.6×	611 0.5×	1.3k 1.1×	1.2k 2.0×	83	7.5k
Richard C. Koya United States	36	4.6k 1.2×	4.2k 1.9×	508 0.4×	2.2k 1.9×	651 1.0×	78	7.5k
Helen Rizos Australia	46	4.1k 1.0×	3.5k 1.6×	514 0.4×	1.3k 1.1×	1.4k 2.3×	142	6.5k
Larry M. Karnitz United States	45	5.9k 1.5×	2.8k 1.3×	1.0k 0.9×	1.2k 1.1×	1.1k 1.7×	87	7.6k
László Buday Hungary	36	4.3k 1.1×	1.4k 0.6×	1.1k 0.9×	936 0.8×	395 0.6×	93	6.0k

Countries citing papers authored by Claudia Wellbrock

Since Specialization

Citations

This map shows the geographic impact of Claudia Wellbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Wellbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Wellbrock more than expected).

Fields of papers citing papers by Claudia Wellbrock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Wellbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Wellbrock. The network helps show where Claudia Wellbrock may publish in the future.

Co-authorship network of co-authors of Claudia Wellbrock

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Wellbrock. A scholar is included among the top collaborators of Claudia Wellbrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Wellbrock. Claudia Wellbrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldaz, Paula, Irene Otero, Karina Ausín, et al.. (2024). Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells. Pharmaceutics. 16(6). 728–728. 2 indexed citations

Otero, Irene, Haritz Moreno, Paula Aldaz, et al.. (2022). The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Journal of Investigative Dermatology. 143(2). 305–316.e5. 17 indexed citations

Gato, María, Miren Zuazo, Hugo Arasanz, et al.. (2017). PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 20(8). 1818–1829. 223 indexed citations

Erice, Oihane, Michael P. Smith, Ibai Goicoechea, et al.. (2015). MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide. Molecular Cancer Therapeutics. 14(5). 1236–1246. 33 indexed citations

Wellbrock, Claudia & Imanol Arozarena. (2015). Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy. Pigment Cell & Melanoma Research. 28(4). 390–406. 151 indexed citations

Smith, Michael P., Helen L. Young, Adam Hurlstone, & Claudia Wellbrock. (2015). Differentiation of THP1 Cells into Macrophages for Transwell Co-culture Assay with Melanoma Cells. BIO-PROTOCOL. 5(21). 53 indexed citations

Smith, Michael P., Berta Sanchez‐Laorden, Kate O’Brien, et al.. (2014). The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNFα. Cancer Discovery. 4(10). 1214–1229. 171 indexed citations

Ferguson, Jennifer, James R. Hitchin, Agata Lichawska-Cieślar, et al.. (2014). Torin1 mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cells. Journal of Cell Science. 127(Pt 6). 1346–56. 37 indexed citations

Smith, Michael P., Jennifer Ferguson, Imanol Arozarena, et al.. (2012). Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma. JNCI Journal of the National Cancer Institute. 105(1). 33–46. 82 indexed citations

10.

Wellbrock, Claudia, Sareena Rana, Hugh Paterson, et al.. (2008). Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF. PLoS ONE. 3(7). e2734–e2734. 202 indexed citations

11.

Meierjohann, Svenja, Elisabeth Wende, Anita Kraiß, Claudia Wellbrock, & Manfred Schartl. (2006). The Oncogenic Epidermal Growth Factor Receptor Variant Xiphophorus Melanoma Receptor Kinase Induces Motility in Melanocytes by Modulation of Focal Adhesions. Cancer Research. 66(6). 3145–3152. 30 indexed citations

12.

Wellbrock, Claudia, Imanol Arozarena, Shawn M. Davidson, et al.. (2006). FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKC epsilon, B-Raf and S6K2. University of Huddersfield Repository (University of Huddersfield). 9 indexed citations

13.

Pardo, Olivier E., Claudia Wellbrock, Muriel Aubert, et al.. (2006). FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2. The EMBO Journal. 25(13). 3078–3088. 144 indexed citations

14.

Wellbrock, Claudia, Jessica C. Hassel, Petra Fischer, et al.. (2005). STAT5 Contributes to Interferon Resistance of Melanoma Cells. Current Biology. 15(18). 1629–1639. 54 indexed citations

15.

Wellbrock, Claudia, et al.. (2005). Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo. International Journal of Cancer. 117(5). 723–729. 18 indexed citations

16.

Goodall, Jane, et al.. (2004). The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation. Molecular and Cellular Biology. 24(7). 2923–2931. 90 indexed citations

17.

Wellbrock, Claudia, Mathew J. Garnett, & Richard Marais. (2003). IL-16 B-Raf in melanoma. Pigment Cell Research. 16(5). 579–579. 1 indexed citations

18.

Gise, Alexander von, Claudia Wellbrock, Brian A. Hemmings, et al.. (2001). Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals. Molecular and Cellular Biology. 21(7). 2324–2336. 155 indexed citations

19.

Wellbrock, Claudia & Manfred Schartl. (1999). Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59^fyn, GRB2 and Shc. European Journal of Biochemistry. 260(1). 275–283. 31 indexed citations

20.

Wellbrock, Claudia, Petra Fischer, & Manfred Schartl. (1999). PI3-Kinase Is Involved in Mitogenic Signaling by the Oncogenic Receptor Tyrosine Kinase Xiphophorus Melanoma Receptor Kinase in Fish Melanoma. Experimental Cell Research. 251(2). 340–349. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact